Covid vaccine for kids

A vaccine developed to protect newborns from RSV, or respiratory syncytial virus, could be authorized by August after decades of development. The vaccine's manufacturer, Pfizer, has stated that the U.S. Food and Drug Administration has accepted its application for review and will decide by August 2023 whether or not to approve the vaccine.